References
Allan M, Harrison P (1980) Co-expression of differentiation markers in hybrids between Friend cells and lymphoid cells and the influence of cell shape. Cell 19:437–447
Aya T, Osato T (1974) Early events in transformation of human cord lymphocytes by Epstein-Barr virus: Induction of DNA synthesis mitosis and the virus-associated nuclear antigen synthesis. Int J Cancer 14:341–347
Baron D, Strominger L (1978) Partial purification and properties of the Epstein-Barr virus-associated nuclear antigen. J Biol Chem 253:2875–2881
Béchet JM, Fialkow P, Nilsson K, Klein G (1974) Immunoglobulin synthesis and glucose-6-phosphate dehydrogenase as cell markers in human lymphoblastoid cell lines. Exp Cell Res 89:275–282
Ben-Sasson SA, Klein G (1981) Activation of the Epstein-Barr virus genome by 5-aza-cytidine in latently infected human lymhoid lines. Int J Cancer 28:131–135
Ber R, Klein G, Moar M, Povey S, Rosén A, Westman A, Yefenof E, Zeuthen J (1978) Somatic cell hybrids between human lumphoma lines. IV. Establishment and characterization of a P3HR-1/Daudi hybrid. Int J Cancer 21:707–719
Berger R, Bernheim A, Weh H-J, Flandria G, Daniel M-T, Brouet J-C, Colbert N (1979) A new translocation in Burkitt's tumor cells. Hum Genet 53:111–112
Bornkamm GW, Delius H, Zimber U, Hudewentz J, Epstein MA (1980) Comparison of Epstein-Barr virus strains of different origin by analysis of the viral DNAs. J Virol 35:603–618
Christiansen G, Christiansen C, Zeuthen J (1983) Complex forms of mitochondrial DNA in human B-cells transformed by Epstein-Barr virus (EBV). J Cancer Res Clin Oncol 105:13–19
Clements GB, Klein G, Zeuthen J, Povey S (1976) The selection of somatic cell hybrids between human lymphoma cell lines. Somatic Cell Genet 2:309–324
Cohen MM, Sagi M, Ben-Zur Z, Schaap T, Voss R, Kohn G (1979) Ataxia telangiectasia: Chromosomal stability of continuous lymphoblastoid cell lines. Cytogenet Cell Genet 23:44–54
Collins SJ, Gallo RC; Gallagher RE (1977) Continuous growth and differentiation of human myeloid leukemia cells in suspension culture. Nature 270:347–350
Croce CM, Shander M, Martinis J, Cicurel L, D'Ancona GG, Koprowski H (1980a) Preferential retention of human chromosome 14 in mouse x human B cell hybrids. Eur J Immunol 10:486–488
Croce C, Linnenbach A, Hall W, Steplewski Z, Koprowski H (1980b) Production of human hybridomas secreting antibodies to measles virus. Nature 288:488–489
Einhorn L, Ernberg I (1978) Induction of EBNA precedes the first cellular S-phase after EBV-infection of human lymphocytes. Int J Cancer 21:157–160
Engblom I, Ernberg I (1981) Ultraviolet inactivation of Epstein-Barr virus-induced nuclear antigen (EBNA), DNA and IgM synthesis in human B lymphocytes. Virology 112:228–239
Eskeland T, Klein E (1971) Isolation of 7S IgM and kappa chains from the surface membrane of tissue culture cells dervied from a Burkitt lymphoma. J Immunol 107:1368–1375
Fellous M, Kamoun M, Wiels J, Dausset J, Clements G, Zeuthen J, Klein G (1977) Induction of HLA expression in Daudi cells after cell fusion. Immunogenetics 5:423–436
Fialkow PJ, Klein G, Gartler SM, Clifford P (1970) Clonal origin for individual Burkitt tumors. Lancet I:384–386
Fialkow PJ, Klein E, Klein G, Clifford P, Singh S (1973) Immunoglobulin and glucose-6-phosphate dehydrogenase as markers of cellular origin in Burkitt lymphoma. J Exp Med 138:89–102
Fleischmann EW, Prigogina EL (1977) Karyotype abnormalities of malignant lymphomas. Hum Genet 35:269–279
Fukuhara S, Rowley JD (1978) Chromosome 14 translocations in non-Burkitt lymphomas. Int J Cancer 22:14–21
Gergely L, Llein G, Ernberg I (1971) Appearance of Epstein-Barr virus associated antigens in infected Raij cells Virology 45:10–21
Given D, Kieff E (1978) DNA of Epstein-Barr virus. VI. Mapping of the internal tandem reiteration. J Virol 31:315–324
Glaser R, Rapp F (1972) Rescue of Epstein-Barr virus from somatic cell hybrids of Burkitt lymphoblastoid cells. J Virol 10:288–296
Glaser R, Nonoyama M (1973) Epstein-Barr virus: Detection of genome in somatic cell hybrids of Burkitt lymphoblastoid cells. Science 179:492–493
Glaser R, Ablashi DV, Nonoyama M, Henle W, Easton J (1977) Enhanced oncogenic behavior of human and mouse cells after cellular hybridization with Burkitt tumor cells. Proc Natl Acad Sci USA 74:2574–2578
Graessmann A, Wolf H, Bornkamm GW (1980) Expression of Epstein-Barr virus genes in different cell types after microinjection of viral DNA. Proc Natl Acad Sci USA 77:433–436
Graessmann A, Graessmann M, Mueller C (1981) Regulation of SV 40 gene expression. Adv Cancer Res 35:111–149
Grogan E, Miller G, Henle W, Rabson M, Shedd D, Niedermann JC (1981) Expression of Epstein-Barr viral early antigen in monolayer tissue cultures after transfection with viral DNA and DNA fragments. J Virol 40:861–869
Hayward S, Kieff E (1976) Epstein-Barr virus specific RNA. I. Analysis of viral RNA in cellular extracts and in polyribosomal fraction of permissive and non-permissive lymphoblastoid cell lines. J Virol 18:518–525
Hayward SD, Kieff E (1977) DNA of Epstein-Barr virus. II. Comparison of the molecular weights of restriction endonuclease fragments of the DNA of Epstein-Barr virus strains and identification of end fragments of the B95-8 strain. J Virol 23:421–429
Hengartner H, Meo T, Müller E (1978) Assignment of genes for immunoglobulin K and heavy chains to chromosomes 6 and 12 in mouse. Proc Natl Acad Sci USA 75:4494–4498
Henle G, Henle W (1966) Immunofluorescence in cells derived from Burkitt's lymphoma. J Bacteriol 91:1248–1256
Henle G, Henle W, Clifford P, Diehl V, Kafuko GW, Kirya BG, Klein G, Morrow RH, Munube GMR, Pike P, Takle PM, Ziegler JL (1969) Antibodies to Epstein-Barr virus in Burkitt's lymphoma and control groups. J Natl Cancer Inst 43:1147–1157
Henle G, Henle W, Zajac B, Pearson G, Waubke R, Scriba M (1970) Differential reactivity of human sera with early antigens induced by Epstein-Barr virus. Science 169:188–190
Henle G, Henle W, Klein G, Gunvén P, Clifford P, Morrow RH, Ziegler JL (1971) Antibodies to early EBV-induced antigens in Burkitt's lymphoma. J Natl Cancer Inst 46:861–871
Hinuma Y, Ohta R, Miyamoto T, Ishida N (1962) Evaluation of the complement method of fluorescent antibody technique with myxoviruses. J. Immunol 89:19–26
Hunter T (1980) Proteins phosphorylated by the RSV transforming function. Cell 22:647–648
Ito Y (1980) Organization and expression of the genome of polyoma virus. In: Klein G (ed), Viral oncology, Raven Press, New York (pp 447–480)
Jondal M, Klein G, Oldstone M, Bokish V, Yefenof E (1976) Surface markers on human B and T lymphocytes. VIII. Association between complement and Epstein-Barr virus (EBV) receptors on human lymphoid cells. Scand J Immunol 5:401–410
Jörnvall H, Luka J, Klein G, Appella E (1982) A 53 K protein common to chemically and virally transformed cells shows extensive sequence similarities between species. Proc Natl Acad Sci USA 79:287–291
Kaiser-McCaw B, Epstein AL, Kaplan AL, Hecht F (1977) Chromosome 14 translocation in African and North American Burkitt's lymphomas. Int J Cancer 19:482–486
Kamata T, Tanaka S, Aikawa S, Hinuma Y, Watanabe Y (1979) A possible function of Epstein-Barr virus-determined nuclear antigen (EBNA): Stimulation of chromatin template activity in vitro. Virology 95:222–226
Kamata T, Takaki K, Hinuma Y, Watanabe Y (1981) Protein kinase activity associated with the Epstein-Barr virus-determined nuclear antigen. Virology 113:512–520
Kaschka-Dierich C, Adams A, Lindahl T, Bornkamm GW, Bjursell G, Klein G, Giovanella BC, Singh S (1976) Intracellular forms of Epstein-Barr virus DNA in human tumor cells in vivo. Nature 260:302–306
Kintner C, Sugden B (1981) Identification of antigenic determinants unique to the surface of cells transformed by Epstein-Barr virus. Nature 294:458–460
Klein G, Clifford P, Klein E, Stjernswärd J (1966) Search for tumor specific immune reactions in Burkitt lymphoma patients by the membrane immunofluorescence reaction. Proc Natl Acad Sci USA 55:1628–1635
Klein G, Clifford P, Klein E, Stjernswärd J (1967) Membrane immunofluorescence reactions of Burkitt's lymphoma cells from biopsy specimens and tissue culture. J Natl Cancer Inst 39:1027–1044
Klein E, Eskeland T, Inoue M, Strom R, Johansson B (1970) Surface immunoglobulin moieties on lymphoid cells. Exp Cell Res 62:133–148
Klein G, Wiener F, Zech L, zur Hausen H, Reedman B (1974) Segregation of the EBV-determined nuclear antigen (EBNA) in somatic cell hybrids derived from the fusion of a mouse fibroblast and a human Burkitt lymphoma line. Int J Cancer 14:54–64
Klein G, Clements G, Zeuthen J, Westman A (1976a) Somatic cell hybrids between human lymphoblastoid cel lines. II. Spontaneous and induced patterns of Epstein-Barr virus (EBV) cycle. Int J Cancer 17:715–724
Klein G, Zeuthen J, Terasaki P, Billing R, Honig R, Jondal M, Westman A, Clements G (1976b) Inducibility of the Epstein-Barr virus (EBV) cycle and surface marker properties of EBV-negative lymphoma lines and their in vitro EBV-converted sublines. Int J Cancer 18:639–625
Klein G, Clements G, Zeuthen J, Westman A (1977a) Spontaneous and induced patterns of the Epstein-Barr virus (EBV) cycle in a new set of somatic cell hybrids. Cancer Lett 3:91–98
Klein G, Terasaki P, Billing R, Honig R, Jondal M, Rosén A, Zeuthen J, Clements G (1977b) Somatic cell hybrids between human lymphoma lines. III. Surface markers. Int J Cancer 19:66–76
Klein G (1978) Cancer, viruses, and environmental factors. In: Kurstak E, Maramorosch K (eds) Viruses and Environment Academic Press, New York, pp 1–12
Klein G (1979) Lymphoma development in mice and humans: Diversity of initiation is followed by convergent cytogenetic evolution Proc Natl Acad Sci USA 76:2442–2446
Klein G, Luka J, Zeuthen J (1980a) Transformation induced by Epstein-Barr virus and the role of the nuclear antigen. Cold Spring Harbor Symp. Quant. Biol 44:253–261
Klein G, Zeuthen J, Eriksson I, Terasaki P, Bernoco M, Rosén A, Masucci G, Povey S, Ber R (1980b) Hybridization of a myeloid leukemia derived cell line (K562) with a Burkitt lymphoma line (P3HR-1) J Natl Cancer Inst 64:725–738
Klein G (1981) The role of gene dosage and genetic transpositions in carcinogenesis. Nature 294:313–318
Klein G, Zeuthen J, Ber R, Ernberg I (1982) Human lymphoma-lymphoma hybrids and lymphoma-leukemia hybrids. II. Epstein-Barr virus induction patterns. J Natl Cancer Inst 68:197–202
Koeffler HP, Sparkes RS, Billings R, Klein G (1981) Somatic cell hybrid analysis of hematopoietic differentiation. Blood 58:1159–1163
Koskimies S (1980) A human lymphoblastoid cell line producing specific antibody against Rh-D antigen.Scand J Immunol 11:73–77
Kozbor D, Steinitz M, Klein G, Koskimies S, Mäkelä O (1979) Establishment of anti-TNP antibody producing human lymphoid lines by preselection for hapten binding followed by EBV transformation. Scand J Immunol 10:187–194
Kozbor D, Lagarde AE, Roder JC (1982) Human anti-tetanus toxoid monolonal antibodies produced by a human myeloma hybridized with an EB-virus transformed cell line. Proc Natl Acad Sci USA 79:6651–6655
Köhler G, Milstein C (1976) Derivation of specific antibody-producing tissue culture and tumor lines by cell fusion. Eur J Immunol 6:511–519
Lane DP, Crawford LV (1979) T antigen is bound to a host protein in SV 40-transformed cells. Nature 278:261–263
Lau R, Nonoyama M, Klein G (1981) Somatic cell hybrids between human lymphoma and human myeloid leukemia cells. I. Induction of resident viral genome transcription and antigen formation by IUdR and TPA. Virology 110:259–269
Lindahl T, Klein G, Reedman BM, Johansson B, Singh S (1974) Relationship between Epstein-Barr virus (EBV) DNA and the EBV-determined nuclear antigen (EBNA) in Burkitt lymphoma biopsies and other lymphoproliferative malignancies. Int J Cancer 13:764–772
Luka J, Siegert W, Klein G (1977) Solubilization of the Epstein-Barr virus-determined nuclear antigen and its characterization as a DNA-binding protein. J Virol 22:1–8
Luka J, Jörnvall H, Klein G (1980) Purification and biochemical characterization of the EBV-determined nuclear antigen (EBNA) and an associated protein with a 53 K subunit. J Virol 35:592–602
Malcolm S, Barton P, Bentley DL, Ferguson-Smith MA, Murphy CS, Rabbitts TH (1982) Assignment of a IGKV locus for immunoglobulin light chains to the short arm of chromosome-2 (2p13-cen) by in situ hybridization using a cRNA probe of HK 101 λ Ch4A. Cytogenet Cell Genet 32:296
Manolov G, Manolova Y (1972) Marker band in one chromosome 14 from Burkitt lymphomas. Nature 237:33–34
Manolova Y, Manolov G, Kieler J, Levan A, Klein G (1979) Genesis of the 14q+ marker in Burkitt lymphoma. Hereditas 90:5–10
Mark J, Ekedahl C, Hagman A (1977) Origin of the translocated segment of the 14q+ marker in non-Burkitt lymphomas. Humangenetik 36:277–282
Martin RG, Oppenheim A (1977) Initiation points for DNA replication in non-transformed and simian virus SV40-transformed Chinese hamster lung cells. Cell 11:859–869
Martin RG (1981) The transformation of cell growth and transmogrification of DNA synthesis by Simian Virus 40. Adv Cancer Res 34:1–68
Matsuoka Y, Takahashi Y, Yagi Y, Moore GE, Pressman D (1968) Synthesis and secretion of immunoglobulins by established cell lines of human hematopoietic origin. J Immunol 101:1111–1120
McBride W, Swan D, Leder P, Hieter P, Hollis G (1982) Chromosomal location of human immunoglobulin light chain constant region genes. Cytogenet Cell Genet 32:297–298
McCaw KB, Hecht F, Harnden DG, Teplitz RJ (1975) Somatic rearrangement of chromosome 14 in human lymphocytes. Proc Natl Acad Sci USA 72:2071–2075
McConnell I, Klein G, Lint TF, Lachmann PJ (1978) Activation of the alternative complement pathway by human B cell lymphoma lines is associated with Epstein-Barr virus transformation of the cells. Eur J Immunol 8:453–460
McKusick VA, Cross HE (1966) Ataxia-teleangiectasia and Swiss type agammaglobulinemia. JAMA 195:739–745
Menezes J, Jondal M, Leibold W, Dorval G (1976) Epstein-Barr virus interaction with human lymphocyte subpopulations: Virus adsorption, kinetics of expression of EBV-associated nuclear antigen (EBNA) and lymphocyte transformation. Infect Immun 13:303–310
Miller G, Lipman M (1973) Release of infectious Epstein-Barr virus by transformed marmoset leukocytes. Proc Natl Acad Sci USA 70:190–194
Miller G, Grogan E, Heston L, Robinson J, Smith D (1981) Epstein-Barr viral DNA: Infectivity for human placental cells. Science 212:452–455
Milner J, Milner S (1981) SV 40–53 K antigen: A possible role for 53K in normal cells. Virology 112:785–788
Mitelman F, Anvret-Andersson M, Brandt L, Catovsky D, Klein G, Manolov G, Manolova Y, Mark-Vendel E, Nilsson PG (1979) Reciprocal 8;14 translocation in EBV-negative B-cell acute lymphocytic leukemia and in a leukemic non-endemic Burkitt lymphoma. Int J Cancer 24:27–33
Mitelman F (1981) Marker chromosome 14q + in human cancer and leukemia. Adv Cancer Res 34:141–167
Moar MH, Ber R, Klein G, Westman A, Eriksson I (1978) Somatic cell hybrids between human lymphoma lines. V. IUdR inducibility and P3HR-1 superinfectability of Daudi/HeLa (DAD) and Daudi/P3HR-1 (DIP-1) cell lines. Int J Cancer 22:669–680
Montagnier L, Gruest J (1979) Cell-density-dependence for growth in agarose of two human lymphoma lines and its decrease after Epstein-Barr virus conversion. Int J Cancer 23:71–76
Nadkarni JS, Nadkarni JJ, Clifford P, Manolov G, Fenyö EM, Klein E (1969) Characteristics of new cell lines derived from Burkitt lymphomas. Cancer 23:64–79
Nilsson K, Pontén J (1975) Classification and biological nature of established human hematopoietic cell lines. Int J Cancer 15:321–341
Nilsson K, Giovanella BC, Stehlin JS, Klein G (1977) Tumorigenity of human hematopoietic cell lines in athymic nude mice. Int J Cancer 20:337–344
Nonoyama M, Pagano JS (1973) Homology between Epstein-Barr virus DNA and viral DNA from Burkitt's lymphoma and nasopharyngeal carcinoma determined by DNA-DNA reassociation kinetics. Nature 242:44–47
Nyormoi O, Klein G, Adams A, Dombos L (1973) Sensitivity to EBV superinfection and IUdR inducibility of hybrid cells formed between a sensitive and a relatively resistant Burkitt lymphoma cell line. Int J Cancer 12:396–408
Ohno S, Luka J, Lindahl T, Klein G (1977) Identification of a purified complement-fixing antigen as the Epstein-Barr virus nuclear antigen (EBNA) by its binding to metaphase chromosomes. Proc Natl Acad Sci USA 74:1605–1609
Olsson L, Kaplan HS (1980) Human hybridomas producing monoclonal antibodies of predefined antigenic specificity. Proc Natl Acad Sci USA 77:5429–5431
Oppenheim A, Shlomai Z, Ben-Bassat H (1981) Initiation points for cellular deoxyribonucleic acid replication in human lymphoid cells converted by Epstein-Barr virus. Mol Cell Biol 1:753–762
Orellana T, Kieff E (1977) Epstein-Barr virus specific RNA. II. Analysis of polyadenylated viral RNA in restringent, abortive and productive infections. J Virol 22:321–330
Otsuka H, Haxen M, Kit M, Quavi H, Kit S (1981) Cloning of the marmoset herpes virus thymidine kinase gene and analysis of the boundaries of the coding region. Virology 113:196–213
Pope JH (1979) Transformation by the virus in vitro. In: Epstein MA, Achong BG (eds) The Epstein-Barr virus. Springer, Berlin Heidelberg New York, pp 205–223
Povey S, Jeremiah S, Arthur E, Ber P, Fialkow PJ, Gardiner E, Goodfellow PN, Karande A, Klein G, Quintero M, Steel CM, Zeuthen J (1981) Deficiency of malic enzyme: A possible marker for malignancy in lymphoid cells. Ann Hum Genet 45:237–252
Pritchett RF, Hayward SD, Kieff ED (1975) DNA of Epstein-Barr virus. I. Comparative studies of the DNA of Epstein-Barr virus from HR-1 and B95-8 cells: Size, structure, and relatedness. J Virol 15:556–569
Purtilo DT, Sakamoto K, Saemundsen AK, Sullivan JL, Synnerholm AC, Anvret M, Pritchard M, Sloper C, Sieff C, Pincott J, Pachman L, Rich K, Cruzi F, Cornet JA, Collins R, Barnes N, Knight J, Sandstedt B, Klein G (1981) Documentation of Epstein-Barr virus infection in immunodeficient patients with lifethreatening lymphoproliferative diseases by clinical, virological, and immunopathological studies. Cancer Res 41:4226–4236
Raab-Traub N, Pritchett R, Kieff E (1978) DNA of Epstein-Barr virus. III. Identification of restriction enzymes that contain DNA sequences which differ among strains of Epstein-Barr virus. J Virol 27:388–398
Reedman BM, Klein G (1973) Cellular localization of an Epstein-Barr virus (EBV)-associated complement-fixing antigen in producer and nonproducer lymphoblastoid cell lines. Int J Cancer 11:499–520
Rickinson AB, Moss DJ, Wallace LE, Rowe M, Misko IS, Epstein MA, Rope JH (1981) Long-term T-cell mediated immunity to Epstein-Barr virus. Cancer Res 41:4216–4221
Ringertz NR, Savage RE (1976) Cell hybrids. Academic Press, New York
Robinson J, Miller G (1975) Assay for Epstein-Barr virus based on the stimulation of DNA synthesis in mixed leukocytes from human umbilical blood. J Virol 15:1065–1072
Rosa MD, Gottlieb E, Lerner MR, Steitz JA (1981) Striking similarities are exhibited by two small Epstein-Barr virus-encoded ribonucleic acids and the adenovirus-associated ribonucleic acids VAI and VAII. Mol Cell Biol 1:785–786
Rosén A, Britton S, Gergely P, Jondal M, Klein G (1977a) Epstein-Barr virus infection of human lymphocytes in vivo. Nature 267:52–54
Rosén A, Clements G, Klein G, Zeuthen J (1977b) Double immunoglobulin production in cloned somatic cell hybrids between two human lymphoid lines. Cell 11:139–147
Rosental KS, Shuman H, Strominger JL (1981) Induction of several new antigens including a T cell-associated antigen, following conversion of the EBV-negative B cell line Ramos to EHR-B Ramos by Epstein-Barr virus. J Immunol 127:746–754
Roubal J, Klein G (1981) Synthesis of thymidine kinase (TK) in Epstein-Barr virus-superinfected Raji TK-negative cells. Intervirology 15:43–48
Roubal J, Källin B, Luka J, Klein G (1981) Early DNA-binding polypeptides of Epstein-Barr virus. Virology 113:285–292
Rowley JD (1980) Chromosome abnormalities in cancer. Cancer Genet Cytogenet 2:175–198
Rutherford TR, Clegg JB, Weatherall DJ (1979) K562 human leukaemic cells synthesize embryonic haemolobin in response to haemin. Nature 280:164–165
Rymo L (1979) Identification of transcribed regions of Epstein-Barr virus DNA in Burkitt lymphoma derived cells. J Virol 32:8–18
Rymo L, Lindahl T, Adams A (1979) Sites of sequence variability in Epstein-Barr virus DNA from different sources. Proc Natl Acad Sci USA 76:2794–2798
Rymo L, Lindahl T, Povey S, Klein G (1981) Analysis of restriction endonuclease fragments of intracellular Epstein-Barr virus DNA and isoenzymes indicate a common origin of the Raji, NC-37 and F-265 human lymphoid cell lines. Virology 115:115–124
Saemundsen AK, Purtilo DT, Sakamoto K, Sullivan JL, Synnerholm AC, Hanto DC, Simmons R, Anvret M, Collins R, Klein G (1981) Documentation of Epstein-Barr virus infection in immunodeficient patients with life-threatening lymphoproliferative diseases by Epstein-Barr virus complementary RNA/DNA and viral DNA/DNA hybridization. Cancer Res 41:4237–4242
Shaw JE, Levinger LF, Carter CW (1979) Nucleosomal structure of Epstein-Barr virus DNA in transformed cell lines. J Virol 29:657–665
Steel CM, Woodward MA, Davidson C, Philipson J, Arthur E (1977) Non-random chromosome gains in human lymphoblastiod cell lines. Nature 270:349–351
Steinitz M, Klein G (1975) Comparison between growth characteristics of an Epstein-Barr virus (EBV)-genome-negative lymphoma line and its EBV-converted subline in vitro Proc Natl Acad Sci USA 72:3518–3520
Steinitz M, Klein G (1976) Epstein-Barr virus (EBV)-induced change in the saturation sensitivity and serum dependence of established, EBV-negative lymphoma lines in vitro. Virology 70:570–573
Steinitz M, Klein G (1977) Further studies on the differences in serum dependence in EBV negative lymphoma lines and their in vitro converted, virus-genome carrying sublines. Eur J Cancer 13:1269–1275
Steinitz M, Klein G, Koskimies S, Mäkelá O (1977) Epstein-Barr virus-induced B-lymphocyte cell lines producing specific antibody. Nature 269:420–422
Steinitz M, Seppälä I, Eichmann K, Klein G (1979) Establishement of a human lymphoblastoid cell line with specific antibody production against group A Streptococcal carbohydrate. Immunobiology 156:41–47
Steinitz M, Izak G, Cohen S, Ehrenfeld M, Fleehner J (1980) Continuous production of rheumatoid factor by in vitro EBV-transformed lymphocytes. Nature 287:443–445
Stenman S, Zeuthen J, Ringertz NR (1975) Expression of SV40 T antigen during the cell cycle of SV40-transformed cells. Int J Cancer 15:547–554
Svedmyr E, Jondal M (1975) Cytotoxic cells specific for B cell lines transformed by Epstein-Barr virus are present in patients with infectuous mononucleosis. Proc Natl Acad Sci USA 72:1622–1626
Tanaka A, Nonoyama M, Glaser R (1977) Transcription of latent Epstein-Barr virus genomes in human epithelial/Burkitt hybrid cells. Virology 82:63–68
Tjian R, Fey G, Graessmann A (1978) Biological activity of purified simian virus 40 T antigen proteins. Proc Natl Acad Aci USA 75:1279–1284
van Den Berghe H, Parloir C, Gosseye S, Englebienne V, Cornu G, Sokal G (1979) Variant translocation in Burkitt lymphoma. Cancer Genet Cytogenet 1:9–14
van Furth R, Gorter H, Nadkarni JS, Klein E, Clifford P (1972) Synthesis of immunoglobulins by biopsied tissues and cell lines from Burkitt's lymphoma. Immunology 22:847–857
Volsky DJ, Shapiro IM, Klein G (1980) Transfer of Epstein-Barr virus receptors to receptor-negative cells permits virus penetration and antigen expression. Proc Natl Acad Sci USA 77:5453–5457
Volsky DJ, Klein G, Volsky B, Shapiro IM (1981) Production of infectious Epstein-Barr virus in mouse lymphocytes. Nature 293:399–401
Yefenof E, Klein G (1976) Difference in antibody induced redistribution of membrane IgM in EBV-genome free and EBV-carrying human lymphoma lines. Exp Cell Res 108:185
Zech L, Haglund U, Nilsson K, Klein G (1976) Characteristic chromosomal abnormalities in biopsies and lymphoid-cell lines from patients with Burkitt and non-Burkitt lymphomas. Int J Cancer 17:47–56
Zeuthen J, Stenman S (1976) Expression of SV40 T antigen during inhibition of DNA synthesis. Cancer Lett 1:219–224
Zeuthen J, Nilsson K (1976) Hybridization of a human myeloma permanent cell line with mouse cells. Cell Differ 4:369–383
Zeuthen J, Stenman S, Fabricius HÅ, Nilsson K (1976) Expression of immunoglobulin synthesis in human myeloma x nonlymphoid cell heterokaryons: Evidence for negative control. Cell Differ 4:369–383
Zeuthen J, Friedrich U, Rosén A, Klein E (1977) Structural abnormalities in chromosome 15 in cell lines with reduced expression of beta-2 microglobulin. Immunogenetics 4:567–580
Zeuthen J, Klein G (1981) Some recent trends in studies of human lymphoid cells: B-cells, Epstein-Barr virus, and transformation. In Neth R, Gallo RC, Graf T, Mannweiler K, Winkler K (eds) Hematology and blood transfusion 26. Modern trends in human leukemia IV. Springer, Berlin Heidelberg, pp 179–190
Zeuthen J, Klein G, Ber R, Masucci G, Bisballe S, Povey S, Terasaki P, Ralph P (1982) Human lymphoma-lymphoma hybrids and lymphoma-leukemia hybrids. I. Isolation, characterization, cell surface markers, and B-cell markers. J Nat Cancer Inst 68:179–195
Ziegler A, Laudien D, Heinrichs H, Müller C, Uchańska-Ziegler B, Wernet P (1981) K562 cells express human major histocompatibility antigens. Immunogenetics 13:359–365
Ziegler A, Uchańska-Ziegler B, Zeuthen J, Wernet P (1982) HLA antigen expression at the single cell level on a K562 x B cell hybrid: An analysis with monoclonal antibodies. Somatic Cell Genet 8:775–789
zur Hausen H, Schulte-Holthausen H, Klein G, Henle W, Henle G, Clifford P, Santesson L (1979a) EBV DNA in biopsies of Burkitt tumours and anaplastic carcinomas of the nasopharynx. Nature 228:1056–1058
zur Hausen H, Bornkamm GW, Schmidt R, Hecker E (1979b) Tumor initiators and promotors in the induction of Epstein-Barr virus. Proc Natl Acad Sci USA 76:782–785
Author information
Authors and Affiliations
Additional information
The “Journal of Cancer Research and Clinical Oncology” publishes in loose succession “Editorials” and “Guest Editorials” on current and/or controversial problems in experimental and clinical oncology. These contributions represent exclusively the personal opinion of the author
Work in the author's laboratory was generously supported by grants from the Danish Natural Science and Medical Research Councils, the Danish Cancer Society, and an award from the Boel Foundation
Rights and permissions
About this article
Cite this article
Zeuthen, J. Epstein-Barr virus (EBV), lymphocytes and transformation. J Cancer Res Clin Oncol 106, 1–11 (1983). https://doi.org/10.1007/BF00399890
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF00399890